טוען...
Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation
[Image: see text] Pharmacological correction of the defective ion channel with cystic fibrosis transmembrane conductance regulator (CFTR) has become an attractive approach to therapy directed at the root cause of the life-limiting disease cystic fibrosis (CF). CFTR defects range from absence, misfol...
שמור ב:
| הוצא לאור ב: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American
Chemical Society
2019
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7088950/ https://ncbi.nlm.nih.gov/pubmed/32259083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.9b00060 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|